Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Tissue factor in hemostasis and thrombosis.

Rachel Tilley1, Nigel Mackman

  • 1Department of Immunology, The Scripps Research Institute, La Jolla, California 92037, USA.

Seminars in Thrombosis and Hemostasis
|February 16, 2006
PubMed
Summary

Tissue factor (TF) is crucial for blood clotting and protecting organs. Aberrant TF expression in diseases like cancer and sepsis is linked to thrombosis, suggesting new therapeutic targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel G13-RAPGEF2-RAP1 signaling pathway critical for platelet adhesion and aggregation.

Blood·2026
Same author

Evaluation of 3 commercial assays for the measurement of tissue factor activity in human plasma.

Research and practice in thrombosis and haemostasis·2026
Same author

Tissue factor detection in mouse tissues by western blotting using commercial antibodies.

Research and practice in thrombosis and haemostasis·2026
Same author

Comparison of changes in blood cells and hemostatic biomarkers in mouse xenograft models of acute myeloid leukemia and acute promyelocytic leukemia.

Research and practice in thrombosis and haemostasis·2026
Same author

Potential Mechanisms Underlying Bleeding During Infection With Hemorrhagic Fever Viruses.

Arteriosclerosis, thrombosis, and vascular biology·2025
Same author

Design, manufacture and evaluation of an offloading 3D printed wheelchair cushion.

Disability and rehabilitation. Assistive technology·2025

Area of Science:

  • Biochemistry
  • Hematology
  • Pathology

Background:

  • Tissue factor (TF) is a key initiator of the coagulation cascade, essential for hemostasis.
  • TF expression is typically localized to specific tissues, providing localized hemostatic control.
  • Aberrant TF expression in the vasculature is implicated in various pathological conditions.

Purpose of the Study:

  • To review the role of tissue factor in hemostasis and disease.
  • To highlight the association between aberrant TF expression and thrombotic events in diseases such as atherosclerosis, cancer, and sepsis.
  • To discuss the potential for developing therapeutic strategies targeting TF for thrombosis treatment while preserving hemostasis.

Main Methods:

  • Literature review and synthesis of existing research on tissue factor function, expression, and its role in disease pathology.
  • Analysis of the link between aberrant TF expression and thrombotic complications.
  • Discussion of potential therapeutic implications and considerations.

Main Results:

  • TF plays a vital role in initiating blood coagulation.
  • Dysregulated TF expression in vascular diseases correlates with increased thrombotic risk.
  • TF is a potential target for antithrombotic therapies.

Conclusions:

  • Targeting TF offers a promising avenue for treating thrombosis associated with diseases like atherosclerosis, cancer, and sepsis.
  • Therapeutic strategies must carefully balance antithrombotic effects with the preservation of normal hemostasis.
  • Understanding TF's dual role in hemostasis and pathology is critical for effective treatment development.

Related Experiment Videos